0(0%) 1:15AM EDT
| Market Cap : 4.38 B | Enterprise Value : 4.38 B | P/E (TTM) : | P/B : |
|---|
VWR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
VWR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
|---|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
|---|
| Joel Greenblatt 46,582 sh (+120.69%) Robert Olstein 506,824 sh (+17.22%) | Jim Simons 186,000 sh (-13.25%) Paul Tudor Jones 11,611 sh (-27.17%) Columbia Wanger 1,390,129 sh (-41.92%) |
| Mario Gabelli 62,600 sh (New) David Dreman 1,196 sh (New) John Paulson 2,675,200 sh (New) Jim Simons 836,700 sh (+349.84%) | Paul Tudor Jones Sold Out Columbia Wanger Sold Out Joel Greenblatt Sold Out Robert Olstein 451,124 sh (-10.99%) |
| Caxton Associates 13,800 sh (New) Mario Gabelli 116,819 sh (+86.61%) | David Dreman 1,196 sh (unchged) | John Paulson Sold Out Jim Simons 829,200 sh (-0.90%) Robert Olstein 364,648 sh (-19.17%) |
| Caxton Associates Sold Out Robert Olstein Sold Out Mario Gabelli Sold Out David Dreman Sold Out Jim Simons Sold Out |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| David Dreman | 2017-12-31 | Sold Out | 0.02% | $33.06 - $33.25 | $ 33.25 | 0% | 0 |  |
| Robert Olstein | 2017-12-31 | Sold Out | 1.56% | $33.06 - $33.25 | $ 33.25 | 0% | 0 | |
| Mario Gabelli | 2017-12-31 | Sold Out | 0.02% | $33.06 - $33.25 | $ 33.25 | 0% | 0 | |
| Robert Olstein | 2017-09-30 | Reduce -19.17% | 0.36% | $32.95 - $33.18 | $ 33.25 | 1% | 364,648 | |
| Mario Gabelli | 2017-09-30 | Add 86.61% | 0.01% | $32.95 - $33.18 | $ 33.25 | 1% | 116,819 | |
| John Paulson | 2017-09-30 | Sold Out | 1.2% | $32.95 - $33.18 | $ 33.25 | 1% | 0 | |
More recent guru trades are included for Premium Members only!! More recent guru trades are included for USA Subscribe Members only!! What is Peter Lynch Charts )| Industry: | Medical Diagnostics & Research » Diagnostics & Research NAICS: 621511 SIC: 8099 | |
|---|---|---|
| Compare: | NAS:NEOG, NAS:BRKR, MIL:DIA, NAS:SYNH, NYSE:CRL, NAS:EXAS, NAS:PRAH, XTER:AFX, SHSE:603658, NAS:FMI, NAS:DXCM, BSP:DASA3, BSP:FLRY3, NAS:ICLR, TSE:4544, SHSE:603882, SZSE:300463, NAS:MYGN, SZSE:300244, NAS:QDEL » details | |
| Traded in other countries: | VW1.Germany, | |
| Headquarter Location: | USA |
| vs
industry |
vs
history |
|---|
| vs
industry |
vs
history |
|---|
| vs
industry |
vs
history |
|---|
| Revenue (TTM) (Mil) $ | 4,639.90 |
|---|---|
| EPS (TTM) $ | 1.14 |
| 52-Week Range $ | 24.42 - 37.25 |
| Shares Outstanding (Mil) | 131.87 |
| Dec17 | Dec18 | Dec19 | |
|---|---|---|---|
| Revenue (Mil $) | 4,707 | 4,863 | 4,970 |
| EBIT (Mil $) | |||
| EBITDA (Mil $) | |||
| EPS ($) | 1.96 | 1.98 | 2.08 |
| EPS without NRI ($) | 1.96 | 1.98 | 2.08 |
| EPS Growth Rate (Future 3Y To 5Y Estimate) | N/A | ||
| Dividends per Share ($) | |||
|
GF Chat
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP